SB 422 requires Montana health insurers to cover FDA-approved drugs for advanced or metastatic cancer without forcing patients to first fail other treatments. It prohibits insurers from demanding that patients prove they've tried and failed alternative drugs before approving coverage for new treatments that align with national cancer guidelines. This directly affects patients diagnosed with advanced or metastatic cancer in Montana, ensuring faster access to potentially life-saving medications without unnecessary bureaucratic hurdles. The law applies only to drugs approved by the FDA and consistent with evidence-based cancer treatment protocols.
SB 537 revises Montana's marijuana tax revenue distribution, directing funds from the marijuana state special revenue account to new and existing state accounts. It requires transferring excess funds annually to specific accounts, including 12% to the HEART account for addiction treatment and mental health programs, 20% to wildlife habitat projects, and 14% to behavioral health initiatives. The bill also allocates funds for law enforcement canine training, sexual assault evidence kits, and homeless shelter support, while modifying existing transfer rules for agencies like the Department of Fish, Wildlife, and Parks. These changes apply to all state agencies receiving marijuana tax revenue under Montana law.
SB 244 requires all health insurance plans sold in Montana to cover behavioral health screenings and assessments at no cost to the insured. This applies to state employee health plans, disability insurance, health maintenance organizations (HMOs), and self-funded workplace plans. Screenings must use standardized, evidence-based tools, but are optional - insured individuals must actively request them. The bill amends Montana insurance codes to include these coverage requirements, ensuring people can access mental health screenings without out-of-pocket costs when they choose to participate.
HB 832 creates a Montana state grant program to fund training for healthcare providers in nonmedication therapies for treating posttraumatic stress disorder (PTSD). The program, administered by the Department of Labor and Industry, awards grants to entities developing 2-year projects that train licensed providers (including Veterans Affairs-certified professionals) in these therapies, develop treatment protocols, and engage in community planning. It appropriates $600,000 from the state general fund for the 2025-2027 biennium as a one-time allocation, requiring grantees to report outcomes like providers trained, patients served, and treatment impact by 2026. The law takes effect July 1, 2025.
HB 610 would have removed a requirement for prior approval (preauthorization) under Montana's Medicaid program for specific FDA-approved antipsychotic drugs. These drugs must be recognized in the latest DSM-5 as effective for certain mental health conditions. The bill would have directly affected Medicaid patients needing these medications and their healthcare providers, who would no longer need to seek pre-approval for covered antipsychotics. The law would have applied to claims for services provided after its effective date. (Note: The bill was vetoed by the governor and the veto override failed, so this policy change did not take effect.)
SB 521 directs Montana's Department of Public Health and Human Services and Office of Public Instruction to create a plan expanding mental health education to all public schools. The plan must include specific elements like curriculum design, funding support strategies, data collection methods, and cost estimates for addressing issues like bullying, suicide, and substance use. All public schools in Montana would be directly affected if the plan is implemented. The bill requires progress reports by September 2025 and a final plan by May 2026. It mandates the development of a roadmap but does not provide immediate funding or require schools to adopt the program.
SB 523, introduced by Senator C. Pope, proposed requiring Medicaid contracts with non-physician providers (like clinics or therapists) to include annual cost-of-living adjustments tied to the U.S. Bureau of Labor Statistics' medical care CPI. This would have mandated that reimbursement rates for these providers increase each year by the same percentage as the medical care inflation rate, rather than relying on fixed formulas. The bill would have applied specifically to non-physician Medicaid service providers, aiming to keep their payments aligned with inflation. However, the bill "died in process" on May 23, 2025, and did not become law.
SB 353 would have expanded Montana's "right to try" law to allow minors with terminal illnesses access to investigational drugs, biological products, or devices. Currently, the law excluded minors from this pathway; this bill would permit eligibility if a minor's treating health care provider attests that the minor has a terminal illness. The bill did not change other existing requirements, such as exhausting approved treatments or obtaining written consent. This change would directly affect minors diagnosed with terminal illnesses seeking experimental treatments not yet approved by the FDA. (Note: The bill died in committee in May 2025 and was never enacted.)
SB 62 would end Montana's Medicaid expansion program for able-bodied adults by prohibiting new enrollments after August 31, 2025, while requiring the Department of Public Health and Human Services to seek a federal waiver to maintain funding for current participants. The bill directly affects individuals enrolled in Montana's Medicaid expansion program who are able-bodied adults, preventing them from joining after the 2025 deadline. Key mechanisms include a strict enrollment cutoff date, a requirement for the department to apply for federal funding continuity, and authorization to implement program integrity measures like biannual eligibility reviews. The bill does not change coverage for individuals with specific health needs or those already enrolled continuously before September 1, 2025.
SB 216 creates Montana's Physicians' Workforce Investment Act, establishing a task force to administer grants for health sector facilities (like hospitals) to launch or expand residency and fellowship programs. The grant program provides up to $2 million per facility to support new graduate medical education programs, requiring applicants to submit accreditation plans, 2-year financial projections, and 5-year sustainability strategies. This directly affects Montana hospitals seeking to train medical graduates (those with medical degrees but without residency completion) and aims to address physician shortages by increasing training opportunities. The task force must report annually on grant usage, program locations, specialty fields, and accreditation status to the legislature.